Pengana International Equities Limited Overview
Pengana International Equities Limited is a mid-sized Australian listed investment company that gives domestic investors exposure to an ethically screened, actively managed portfolio of global listed equities, packaged with quarterly fully franked dividends. Before 2026 it described itself as the largest international ethical LIC on the ASX. For most of the past decade it has traded at a persistent discount to net tangible assets and underperformed its MSCI World benchmark: the five-year return to July 2025 was 9.3% a year against 16.3% for the index. That record triggered a 2025–2026 governance upheaval. Wilson Asset Management replaced most of the board in October 2025, and the reconstituted board ran a strategic review. That review produced a 12.5-cent special dividend, an equal-access buy-back that retired 58.6% of the share capital at after-tax NTA, and a mandate change to Antipodes' global small- and mid-cap strategy. PIA now enters FY2027 as a much smaller (about A$130 million) vehicle with a new strategy, a refreshed board and an unresolved question about recapitalisation.
Company's own description
In its FY2025 Annual Report, PIA described itself as an Australian LIC whose operating activity is investing Australian capital into global businesses. Its stated corporate objective is to provide shareholders with regular, reliable and fully franked dividends as well as capital growth. The investment strategy under Harding Loevner was to invest in high-quality, growing global businesses to deliver superior risk-adjusted returns. Monthly reports continued to describe PIA as the largest international ethical LIC on the ASX, aiming for capital growth plus regular, reliable, fully franked dividends.
The FY2026 Annual Report repeats this objective. It adds that the portfolio is primarily equities, is currently unhedged, and may use forward FX contracts for risk management. It also frames the Antipodes transition as the next phase of the company.
Business model and "revenue model"
PIA's economics are those of a closed-end fund:
Income sources: dividends from investee companies (A$3.5m in FY2026), interest on custodial cash (A$0.3m), and net realised and unrealised gains on the portfolio (A$10.2m in FY2026). Gains dominate and are fully mark-to-market, so reported "revenue" swings with markets.
Cost base: an external management fee of 1.2% a year (ex-GST, net of reduced input tax credits) of gross portfolio value, payable monthly to PIML. There is also a 15% performance fee on outperformance of the MSCI World Total Return Index (net, AUD), subject to a high-water mechanism. A cumulative underperformance of about A$150.25 million must be recouped before any performance fee becomes payable, equal to roughly A$23.1 million of foregone fees (FY2026 Annual Report, Note 2). Administrative costs (directors' fees, audit, registry, listing, custody, brokerage) were about A$1.0–1.2m a year before FY2026. FY2026 added about A$1.4m of one-off governance costs.
Distribution model: profits are moved to a profit reserve, and quarterly fully franked dividends are paid from it. Franking credits come mainly from Australian tax PIA pays on its realised gains, because its foreign investees provide few franking credits.
Mix: 100% investment income. There is no product, service, subscription or licensing revenue.
Value-chain position, customers and end-markets
PIA sits at the end of the asset-management value chain as the capital pool itself. It outsources portfolio management (to PIML, which sub-delegated to Harding Loevner and now Antipodes), administration (PCG), custody (BNP Paribas), registry (Computershare) and company secretarial work (Acclime).
Its "customers" are its shareholders: 4,734 holders at 29 July 2026, down from 5,055 at 23 July 2025 and about 6,100 in August 2023. Register concentration is high: holders of more than 100,000 shares owned 66.15% of capital in July 2026. The end-market is Australian retail, SMSF and adviser-platform investors seeking offshore equity exposure with franked income, plus activist and discount-arbitrage investors (Wilson Asset Management, Saba Capital) and strategic holders (Washington H. Soul Pattinson).
Independent characterisation
In analytical terms, PIA has been a sub-scale, externally managed global equity LIC whose product proposition (ethical screen plus franked dividends) did not overcome three structural headwinds:
-
Benchmark-relative underperformance under successive managers.
-
A management fee (1.2% of gross assets) that is high relative to passive and ETF alternatives.
-
A persistent discount to NTA, measured at 15.1% to pre-tax NTA at 30 June 2025.
The FY2026 restructuring effectively liquidated about 59% of the vehicle at NTA and re-based the remainder on a higher-alpha-potential small/mid-cap mandate. The investment case is now a bet on Antipodes' stock-picking and on the board's ability to rebuild scale and close the discount.
Strategy
Stated strategy (themes from the FY2026 Annual Report and EGM materials)
-
Fix the discount and give shareholders choice. The board described the Capital Management Proposal as designed to address the persistent NTA discount and give holders a genuine choice: exit near NTA, or stay invested.
-
Change manager. Antipodes replaces Harding Loevner, whose performance as sub-manager had, in the board's words, not met expectations. The board chose Antipodes' global small and mid-cap strategy for its disciplined, high-conviction, valuation-focused approach and emphasis on risk management.
-
Sustain franked income. Quarterly fully franked dividends are to continue, subject to profits and franking capacity. The FY2026 report projects that a 5.60c annual rate could be sustained into FY2027, franked at 25%.
-
Ongoing discount control. After a stabilisation period, a rolling quarterly buy-back within regulatory limits will be considered.
-
Rebuild scale. A conditional non-renounceable 1-for-1 rights issue at NTA was proposed, provided the company retained a minimum viable scale. It was deferred on 30 September 2026 pending the reconstituted board's own review.
Initiatives register (last 24 months)
| Date | Initiative | Status | Target / metric |
|---|---|---|---|
| 21 Aug 2025 | Leveraged global private credit sleeve via PCG and Mercer | Rejected at AGM, 21 Oct 2025 | 4.5% p.a. return over debt cost; dividend up 56% to 8.4c, paid monthly |
| 29 Aug 2025 | Suspension of on-market DRP-offset buy-back | Done (45,000 shares bought before suspension) | Not applicable |
| 21 Oct 2025 | Comprehensive strategic review; proposals invited by 14 Nov 2025 | Completed March 2026 | Options covering mandate, manager, capital management and structure |
| 24 Nov 2025 | Independent Board Committee with insider-proposal protocols | Dissolved March 2026 | Manage WAM-related conflict |
| Nov 2025 | Outsourced company secretary (Acclime) | Done | Independence from PCG |
| FY2026 | Board fee reduction (Chair 66.9k to 50k; NED 44.6k to 30k) | Done | Cost discipline |
| 8 May 2026 | Integrated Capital Management Proposal | Approved 27 Jul 2026 | Exit at after-tax NTA |
| 26 Jun 2026 | 12.5c fully franked special dividend (A$32.2m) | Paid 19 Aug 2026 | Distribute franking credits before register change |
| Jul–Sep 2026 | Off-market equal-access buy-back | Completed 29 Sep 2026: 58.6% bought back at A$1.2132 | Not applicable |
| 16 Sep 2026 | Antipodes appointed as sub-investment manager | Transition underway | Antipodes Global SMID strategy |
| Oct 2026 (deferred) | 1-for-1 rights issue at NTA | Deferred 30 Sep 2026 | Rebuild asset base |
| Post-stabilisation | Rolling quarterly buy-back | Proposed | Discount management |
| 2,026 | Minimum Viable Entity Threshold test | Satisfied (board, 30 Sep 2026) | No wind-up resolution |
Medium-term financial targets / guidance
PIA gives no earnings guidance; the board states that forecasting profit is difficult given market volatility. The only quantified forward statements are:
-
The capacity to sustain a 5.6c a year fully franked dividend into FY2027.
-
Weekly NTA reporting.
-
The intention (not commitment) to introduce discount-management buy-backs.
ESG commitments are limited to the continuation of the negative-screen ethical framework. Whether the ethical screen carries over unchanged to the Antipodes mandate was not explicitly confirmed in sources reviewed. PCG's March 2026 announcement said PIA would continue to invest in diversified, ethically screened global equities.
Products & Services
PIA issues one security, its ordinary shares. The "product" is the investment exposure those shares provide. The catalogue below covers each element of the shareholder proposition and the underlying strategies.
Top holdings at 30 June 2026 (last disclosed full portfolio under Harding Loevner):
Source: FY2026 Annual Report, unaudited investment schedule. The schedule appears to contain at least one labelling error: a second "Diploma PLC" line carries a JPY code, most likely a Japanese industrial. This is a data-quality observation.
Because the Antipodes SMID strategy targets a different market-cap universe, this mega-cap-heavy portfolio is expected to be largely replaced during the transition. The post-transition holdings were not publicly disclosed as at the research date.
Product Portfolio
| Offering | Description | Key specifications | Target investor | Launch / latest version | Pricing / fees |
|---|---|---|---|---|---|
PIA ordinary shares (ASX: PIA) | Listed closed-end exposure to a global equity portfolio | 106,900,785 shares post-buy-back; daily ASX liquidity; weekly and monthly NTA disclosure | Australian retail, SMSF and adviser platforms | Listed 19 Mar 2004 | Brokerage only; underlying 1.2% p.a. management fee on gross portfolio plus 15% performance fee over benchmark |
Harding Loevner Global Equity strategy (legacy) | Bottom-up quality-growth global equity, 1989 inception | Four criteria: competitive advantage, quality management, financial strength, sustainable growth; 14-point governance checklist; 38-factor ESG scorecard; benchmark MSCI World TR (net, AUD) | As above | Applied to PIA from May 2021 | Within the 1.2% fee |
Antipodes Global SMID strategy (new) | Global small and mid-cap equities, Antipodes' pragmatic value approach | Rated "Recommended" by Lonsec and Zenith (per PIA FY2026 Annual Report); detailed PIA-specific mandate parameters not yet published | As above | Transition commencing after 29 Sep 2026 | Fee terms of the Antipodes sub-mandate and any IMA amendment: not publicly disclosed in sources reviewed |
Ethical screen | Negative screening across 12–13 exclusion categories | Exclusions include adult content, alcohol, non-regulatory animal testing, fossil fuels (GICS 101020), gambling, nuclear, human-rights abuses, UN-sanctioned issuers, GMOs in agriculture, severe ecosystem impact, mining (GICS 151040), tobacco and weapons; materiality generally above 5% of production or 15% of revenue | Values-aligned investors | Since 2004 (Hunter Hall heritage) | Not separately priced |
Quarterly fully franked dividend | Regular income from profit reserve and franking account | 1.35c a quarter (FY2022–FY2025), 1.40c a quarter from March 2026; franked at 25% | Income-seeking investors | Quarterly payments since c. 2020 (10th consecutive by FY2023) | Not applicable |
Special dividend (2026) | One-off 12.5c fully franked | Paid 19 Aug 2026; A$32.2m | All shareholders pre-buy-back | Declared 26 Jun 2026 | Not applicable |
Dividend Reinvestment Plan | Reinvest dividends into new shares | Historically priced at 5-day VWAP with no discount; suspended for the final FY2026 dividend | Long-term holders | Active FY2022–FY2026 | No brokerage |
Off-market equal-access buy-back (2026) | Exit at after-tax NTA less costs | Up to 100% of shares; price A$1.2132 (NTA less A$0.0015 costs); 58.6% accepted | All holders at 7 Aug 2026 record date | Approved 27 Jul 2026; completed 29 Sep 2026 | Transaction costs A$0.0015 per share |
Proposed rolling quarterly buy-back | Ongoing discount control mechanism | Within regulatory limits; subject to solvency and board discretion | Continuing holders | Proposed post-stabilisation; not yet implemented | Not applicable |
Conditional 1-for-1 non-renounceable rights issue | Recapitalisation at after-tax NTA | Originally timetabled for October 2026 (ex-date 8 Oct, record 9 Oct); deferred 30 Sep 2026 pending board review | Continuing holders | Deferred | Issue price at NTA (per original terms) |
Proposed private credit sleeve (rejected) | Leveraged global private credit fund-of-funds (Mercer-advised, PCG-managed) | Bank loan secured on the equity portfolio; target 4.5% p.a. above cost of debt; PCG to cover any debt-cost shortfall; dividend target 8.4c monthly | Income investors | Proposed 21 Aug 2025; rejected 21 Oct 2025 | PCG to receive no management fee but a share of returns above target |
| Holding | Sector | Market value (AUD K) | % of gross assets |
|---|---|---|---|
Alphabet | Communication Services | 15,713 | 4.4 |
NVIDIA | Information Technology | 15,234 | 4.3 |
Taiwan Semiconductor | Information Technology | 14,305 | 4.0 |
Amazon | Consumer Discretionary | 13,942 | 3.9 |
Samsung Electronics | Information Technology | 13,794 | 3.9 |
Schneider Electric | Industrials | 11,680 | 3.3 |
AMETEK | Industrials | 10,042 | 2.8 |
Johnson & Johnson | Health Care | 9,735 | 2.7 |
ASML | Information Technology | 9,596 | 2.7 |
HEICO | Industrials | 9,505 | 2.7 |
Financial Narrative
All figures in AUD thousands unless stated. FY2022–FY2023 from the FY2023 Annual Report; FY2024–FY2025 from the FY2025 Annual Report; FY2026 from the FY2026 Annual Report and Appendix 4E. Ratios marked "derived" are analyst calculations from audited figures.
Income statement
Notes: The FY2026 ordinary dividends of 5.55c comprise 1.35c (Dec 2025), 1.40c (Mar 2026), 1.40c (Jun 2026) and a 1.40c final declared 26 July 2026 and paid 15 September 2026. Gross profit, operating income and EBITDA are not meaningful for an LIC: there is no cost of sales, depreciation, amortisation or interest expense, so EBITDA is effectively equal to profit before tax.
Margins and growth (derived)
FY2022 margins are left blank because income was negative. Average net assets for FY2022 use 1 July 2021 equity of A$361.8m.
Revenue CAGR: Not meaningful. Total investment income is a market-driven figure that moved from -A$79.4m to +A$14.3m. Measured FY2023 to FY2026, it fell at a 36.5% compound annual rate (derived), which reflects relative underperformance and the market path, not business contraction.
Commentary. The cost structure is the key structural feature. Management fees (about 1.2–1.3% of net assets) absorbed between 8% and 31% of gross investment income in positive years. In FY2026, the A$1.39m of one-off governance costs (AGM 2025 expenses of A$996k and strategic review legal and professional costs of A$395k) pushed total expenses to 2.05% of average net assets, the highest in the five-year window. The inflection is FY2026: the portfolio's total portfolio return (TPR) of 2.1% against an 18.5% benchmark gain (FY2026 Annual Report) caused an 82.3% fall in NPAT, even though global equities were strong.
Balance sheet
Notes: FY2024 after-tax NTA per share is derived (net assets ÷ shares). FY2022 pre-tax NTA was below after-tax NTA because unrealised losses created a deferred tax asset. Working capital is not a meaningful concept: the balance sheet is presented on a liquidity basis, and liquid assets exceed liabilities by more than 7 times in every year.
Post-balance-date pro forma (derived, illustrative): After paying the A$32.2m special dividend (19 Aug 2026), the A$1.40c final dividend (about A$3.6m, 15 Sep 2026) and A$183.3m of buy-back consideration (6–9 Oct 2026), net assets fall to roughly A$129–131m. That is 106.9m shares at an after-tax NTA of about A$1.21, consistent with the A$1.2132 buy-back price.
Cash flow
Note: In an LIC, operating cash flow includes net investment trading, so "free cash flow" is mostly a function of net portfolio selling. It is shown for completeness but should not be read as recurring cash generation.
Commentary. FY2024 stands out for portfolio turnover of about 130% of average investments (A$421.5m of sales), which pushed aggregated turnover to A$116.6m. That disqualified PIA from base-rate entity status for that year and raised its tax rate to 30% (FY2025 Annual Report, Note 3), which explains the elevated 30.3% effective tax rate. The large FY2025 tax payment (A$16.9m) on FY2024 realised gains then rebuilt the franking account from A$3.5m to A$14.4m. That franking capacity is what allowed the board to fund the 12.5c special dividend in 2026 and still project that a 5.6c annual dividend could be sustained into FY2027.
Ratios (derived)
Notes and discrepancies:
FY2025 TPR: the FY2025 Chair's letter reports 12.6% (Directors' Report: 12.56%), but the FY2026 Annual Report states the FY2025 comparative TPR as 11.0%. The two filings conflict; the original FY2025 figure is shown above.
-
Interest coverage, net debt/EBITDA, asset turnover and cash conversion cycle are not applicable because there is no debt, inventory or receivables cycle.
-
Longer-term record: the fund returned 9.3% a year over five years to 31 July 2025, against 16.3% for the index (Capital Brief, citing Pengana data).
Trend commentary
-
Absolute returns were adequate; relative returns were persistently poor. PIA lagged the MSCI World in every year where both figures are available. The gap widened sharply in FY2026 (-16.4 percentage points), when concentrated AI and mega-cap leadership and a rally in excluded sectors (defence, resources) penalised a diversified, ethically screened quality-growth book. Harding Loevner's style headwinds are acknowledged in the FY2026 Annual Report.
-
The NTA per share compounded weakly. After-tax NTA rose from A$1.12 (FY2022) to a A$1.37 peak (FY2025), then fell back to A$1.21 (FY2026). The FY2026 decline came from the 12.5c special dividend accrued at balance date (about A$0.125 per share) and weak performance.
-
The capital base was static until 2026. DRP issuance was largely offset by buy-backs, keeping shares at about 256–258 million for five years. Without primary capital-raising capacity (because of the discount), the fixed-cost base could not be spread over a larger asset pool.
-
The balance sheet was conservative. No leverage, Level 1 assets only, and full liquidation within one month at 10% of average daily volume (FY2026 Annual Report, Note 14). The rejected private credit proposal would have introduced secured leverage for the first time.
-
FY2026 was an inflection year. Profit collapsed, governance costs spiked, and the company was then roughly 59% liquidated through the buy-back. FY2027 accounts will reflect a much smaller base, so the fixed-cost ratio will rise unless the vehicle is recapitalised.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Income component (AUD K)
| Income component (AUD K) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Dividends received (AUD K) | 2,023 | 2,329 | 2,821 | 3,268 | 3,542 |
Interest received (AUD K) | 2 | 292 | 395 | 438 | 337 |
Net gains or losses on financial instruments at FVTPL (AUD K) | -81,377 | 53,117 | 50,141 | 45,994 | 10,244 |
FX gains or losses on foreign currency cash (AUD K) | 2 | -8 | 6 | -15 | 13 |
Other operating income (AUD K) | 0 | 1 | 0 | 2 | 142 |
Total investment income (AUD K) | -79,350 | 55,731 | 53,363 | 49,687 | 14,278 |
Component share of total investment income (%)
| Component share of total investment income (%) | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|
Dividends (% of total) | 4.2 | 5.3 | 6.6 | 24.8 |
Interest (% of total) | 0.5 | 0.7 | 0.9 | 2.4 |
Net investment gains (% of total) | 95.3 | 94.0 | 92.6 | 71.7 |
Revenue by Segment (%)
| GICS sector (% of gross assets) | FY2025 | FY2026 |
|---|---|---|
Information Technology (%) | 24.3 | 27.6 |
Industrials (%) | 17.1 | 22.7 |
Communication Services (%) | 15.1 | 12.7 |
Health Care (%) | 14.9 | 11.9 |
Financials (%) | 11.8 | 11.5 |
Consumer Discretionary (%) | 9.6 | 8.5 |
Consumer Staples (%) | 1.8 | 1.1 |
Materials (%) | 0.9 | 0.0 |
Real Estate (%) | 1.1 | 0.0 |
Total equities (%) | 96.5 | 96.1 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansGroup Structure
| Layer | Entity | Role |
|---|---|---|
Board | PIA Board | Governance, capital management, oversight of the IMA |
Investment Manager | Pengana Investment Management Limited (AFSL 219462), subsidiary of PCG | Contracted manager under the 2004 IMA; fee recipient |
Sub-investment manager (to Sep 2026) | Harding Loevner LP, Bridgewater, New Jersey | Global Equity (quality-growth) strategy |
Sub-investment manager (from post-buy-back 2026) | Antipodes Partners Limited, Sydney (Pinnacle affiliate) | Global SMID strategy |
Administration | Pengana Capital Group Limited | Financial management, marketing, operations |
Company secretary | Acclime Listed Services Australia Pty Ltd (Sandra McIntosh) | ASX and secretarial functions since Nov 2025 |
Custodian | BNP Paribas (A-1 short-term rating) | Asset safekeeping |
Registry | Computershare | Share register, DRP |
Auditor | Ernst & Young | Statutory audit |
Income Statement and Per-Share Data
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Total investment income — "revenue" (AUD K) | -79,350 | 55,731 | 53,363 | 49,687 | 14,278 |
Management fees (AUD K) | 4,367 | 3,556 | 4,025 | 4,460 | 4,376 |
Performance fees (AUD K) | 0 | 0 | 0 | 0 | 0 |
Other operating expenses (AUD K) | 1,161 | 913 | 1,116 | 968 | 2,458 |
Total expenses (AUD K) | 5,528 | 4,469 | 5,141 | 5,428 | 6,834 |
Profit before tax (AUD K) | -84,878 | 51,262 | 48,222 | 44,259 | 7,444 |
Income tax expense, negative = benefit (AUD K) | -23,227 | 12,906 | 14,597 | 10,498 | 1,454 |
Net profit after tax (AUD K) | -61,651 | 38,356 | 33,625 | 33,761 | 5,990 |
EPS basic and diluted (AUD cents) | -24.14 | 14.96 | 13.08 | 13.13 | 2.33 |
Weighted average shares (millions) | 255.43 | 256.47 | 257.08 | 257.16 | 257.49 |
Ordinary dividends declared per share (AUD cents) | 5.40 | 5.40 | 5.40 | 5.40 | 5.55 |
Special dividend declared per share (AUD cents) | 0 | 0 | 0 | 0 | 12.50 |
Dividends paid in the year per share (AUD cents) | 5.40 | 5.40 | 5.40 | 5.40 | 5.50 |
Margin Analysis (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Pre-tax margin, PBT / total investment income (%) | — | 92.0 | 90.4 | 89.1 | 52.1 |
Net margin, NPAT / total investment income (%) | — | 68.8 | 63.0 | 67.9 | 42.0 |
Effective tax rate (%) | 27.4 | 25.2 | 30.3 | 23.7 | 19.5 |
Total expenses / average net assets (%) | 1.70 | 1.49 | 1.59 | 1.58 | 2.05 |
Management fee / average net assets (%) | 1.35 | 1.18 | 1.25 | 1.30 | 1.31 |
Dividend income / average net assets (%) | 0.62 | 0.78 | 0.87 | 0.95 | 1.06 |
Balance Sheet and Share Count (millions)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Cash and cash equivalents (AUD K) | 10,834 | 9,698 | 14,042 | 8,710 | 13,707 |
Financial assets at fair value (AUD K) | 264,594 | 304,745 | 337,501 | 350,503 | 343,646 |
Trade and other receivables (AUD K) | 428 | 843 | 279 | 6,064 | 342 |
Tax assets, current plus deferred (AUD K) | 12,591 | 7,481 | 34 | 654 | 41 |
Total assets (AUD K) | 288,447 | 322,767 | 351,856 | 365,931 | 357,736 |
Total debt (AUD K) | 0 | 0 | 0 | 0 | 0 |
Net debt, negative = net cash (AUD K) | -10,834 | -9,698 | -14,042 | -8,710 | -13,707 |
Dividend payable (AUD K) | 0 | 0 | 0 | 0 | 32,247 |
Deferred tax liabilities (AUD K) | 50 | 9,410 | 1,210 | 11,036 | 9,971 |
Current tax liabilities (AUD K) | 0 | 0 | 15,614 | 0 | 1,680 |
Total liabilities (AUD K) | 916 | 9,917 | 18,921 | 13,132 | 44,361 |
Total equity / net assets (AUD K) | 287,531 | 312,850 | 332,935 | 352,799 | 313,375 |
Goodwill and intangibles (AUD K) | 0 | 0 | 0 | 0 | 0 |
Issued capital (AUD K) | 318,407 | 319,212 | 319,552 | 319,540 | 320,533 |
Profit reserve (AUD K) | 163,823 | 188,337 | 208,082 | 227,958 | 187,541 |
Retained losses (AUD K) | -194,699 | -194,699 | -194,699 | -194,699 | -194,699 |
Shares on issue at year end (millions) | 256.03 | 256.84 | 257.17 | 257.17 | 257.98 |
NTA per share after tax (AUD) | 1.12 | 1.22 | 1.29 | 1.37 | 1.21 |
NTA per share before tax on unrealised gains (AUD) | 1.08 | 1.25 | — | 1.41 | 1.25 |
Cash Flow and Margin Analysis (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Net operating cash flow (AUD K) | 16,930 | 11,909 | 17,878 | 8,580 | 18,151 |
Proceeds from sale of investments (AUD K) | 125,463 | 75,537 | 421,503 | 139,655 | 177,777 |
Purchases of investments (AUD K) | 98,011 | 63,289 | 402,072 | 112,486 | 156,567 |
Income tax paid, negative = refund (AUD K) | 6,972 | -1,564 | -264 | 16,906 | 226 |
Capex (AUD K) | 0 | 0 | 0 | 0 | 0 |
Free cash flow, equal to OCF (AUD K) | 16,930 | 11,909 | 17,878 | 8,580 | 18,151 |
Cash dividends paid (AUD K) | 12,616 | 12,653 | 12,735 | 12,435 | 13,110 |
Dividends reinvested via DRP (AUD K) | 1,175 | 1,189 | 1,145 | 1,450 | 1,050 |
Share buy-backs (AUD K) | 0 | 384 | 805 | 1,462 | 57 |
Portfolio turnover, sales / average investments (%) | — | 26.4 | 130.0 | 40.6 | 51.2 |
Margin Analysis (%) and Financial Ratios (x)
| Ratio | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
ROE, NPAT / average equity (%) | -19.0 | 12.8 | 10.4 | 9.8 | 1.8 |
ROA, NPAT / year-end total assets (%) | -21.4 | 11.9 | 9.6 | 9.2 | 1.7 |
ROIC, equal to ROE given no debt (%) | -19.0 | 12.8 | 10.4 | 9.8 | 1.8 |
Equity / total assets (%) | 99.7 | 96.9 | 94.6 | 96.4 | 87.6 |
Debt / equity (x) | 0 | 0 | 0 | 0 | 0 |
Liquid assets / total liabilities (x) | 300.7 | 31.8 | 18.6 | 27.9 | 8.1 |
Dividend payout, ordinary DPS / EPS (%) | — | 36.1 | 41.3 | 41.1 | 238.2 |
Franking account balance at year end (AUD K) | 14,547 | 8,369 | 3,478 | 14,434 | 9,941 |
Total portfolio return, net (%) | — | 20.2 | — | 12.6 | 2.1 |
MSCI World TR Index, net, AUD (%) | — | 22.4 | — | 14.6 | 18.5 |
Relative return vs benchmark (percentage points) | — | -2.2 | — | -2.0 | -16.4 |
Total shareholder return excluding franking (%) | — | 23.3 | — | 11.0 | 12.9 |
Revenue by Region
| Currency of investments (AUD K) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
US dollar (AUD K) | 184,006 | 211,380 | 249,398 | 235,644 | 234,589 |
Euro (AUD K) | 21,694 | 31,534 | 33,738 | 21,247 | 26,593 |
Japanese yen (AUD K) | 6,033 | 11,636 | 15,103 | 23,475 | 19,995 |
New Taiwan dollar (AUD K) | 0 | 0 | 0 | 0 | 14,305 |
Hong Kong dollar (AUD K) | 19,560 | 9,623 | 8,972 | 14,380 | 13,211 |
British pound (AUD K) | 6,047 | 5,633 | 9,140 | 15,242 | 12,300 |
Swiss franc (AUD K) | 4,667 | 6,130 | 5,604 | 7,172 | 7,287 |
Swedish krona (AUD K) | 10,218 | 12,682 | 7,576 | 12,943 | 5,811 |
Chinese yuan (AUD K) | 498 | 0 | 0 | 4,967 | 5,685 |
Canadian dollar (AUD K) | 0 | 0 | 0 | 3,444 | 3,870 |
Danish krone (AUD K) | 2,587 | 4,275 | 2,693 | 2,086 | 0 |
Indonesian rupiah (AUD K) | 4,257 | 8,459 | 2,950 | 2,340 | 0 |
Brazilian real (AUD K) | 2,365 | 3,393 | 1,961 | 0 | 0 |
Singapore dollar (AUD K) | 0 | 0 | 0 | 4,493 | 0 |
Mexican peso (AUD K) | 0 | 0 | 366 | 3,070 | 0 |
Polish zloty (AUD K) | 1,691 | 0 | 0 | 0 | 0 |
Total investments (AUD K) | 264,594 | 304,745 | 337,501 | 350,503 | 343,646 |
Revenue by Region (%)
| Region (% of investments) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
United States dollar listings (%) | 69.5 | 69.4 | 73.9 | 67.2 | 68.3 |
Europe incl. UK, Switzerland, Nordics, Poland (%) | 17.6 | 19.8 | 17.4 | 16.9 | 15.0 |
Asia-Pacific ex-Japan, HK/CN/TW/ID/SG (%) | 9.2 | 5.9 | 3.5 | 7.4 | 9.6 |
Japan (%) | 2.3 | 3.8 | 4.5 | 6.7 | 5.8 |
Americas ex-US, Brazil/Mexico/Canada (%) | 0.9 | 1.1 | 0.7 | 1.9 | 1.1 |
Capital Markets Data (AUD) and Margin Analysis (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Share price at 30 June (AUD) | 0.875 | 1.025 | — | — | — |
NTA after tax at 30 June (AUD) | 1.12 | 1.22 | 1.29 | 1.37 | 1.21 |
NTA before tax at 30 June (AUD) | 1.08 | 1.25 | — | 1.41 | 1.25 |
Discount to pre-tax NTA at 30 June (%) | 19.0 | 18.0 | — | 15.1 | — |
Ordinary DPS declared (AUD cents) | 5.40 | 5.40 | 5.40 | 5.40 | 5.55 |
Special DPS declared (AUD cents) | 0 | 0 | 0 | 0 | 12.50 |
Shares bought back (millions) | 0 | 0.42 | 0.72 | 1.25 | 0.05 |
Valuation Snapshot
| Multiple | Value | Comment |
|---|---|---|
Price / after-tax NTA (x) | 1.00 | By construction at the buy-back price |
P/E on FY2026 EPS (x) | 52.1 | Not meaningful for a mark-to-market LIC |
P/E on FY2025 EPS (x) | 9.2 | Not meaningful |
Trailing dividend yield, ordinary 5.55c (%) | 4.6 | 6.1% gross-up at 25% franking (derived) |
Analyst Conclusions
Management guidance
PIA gives no earnings guidance. Its explicit forward statements are:
-
The intention to continue quarterly fully franked dividends, with capacity for a 5.6c annual rate into FY2027.
-
A board review of capital management alternatives, including the deferred rights issue.
-
Consideration of a rolling quarterly buy-back after stabilisation.
-
Completion of the portfolio transition to Antipodes Global SMID.
-
Recruitment of additional independent directors under Gooch's interim chairmanship.
Consensus growth expectations: none (no analyst coverage identified).
Bull case
-
Discount structurally addressed. The NTA-priced exit removed the most discount-sensitive sellers. A rolling quarterly buy-back would anchor the price near NTA for continuing holders, a feature few LICs offer.
-
Better-suited mandate. Antipodes' SMID strategy is independently rated and, according to PIA, award-winning. It gives exposure to a market segment that has lagged mega-caps, so the valuation starting point is more favourable than Harding Loevner's mega-cap quality-growth book offered in 2025–26.
-
Fee and franking optionality. No performance fee is payable until about A$150m of cumulative underperformance is recouped. Realising the A$9.97m DTL during transition will generate franking credits, supporting the 5.6c dividend.
Bear case
-
Scale and cost drag. At about A$130m, fixed costs (more than A$1.0m a year before one-offs) plus a 1.2% gross-asset fee push the total expense ratio toward or above 2%. Without a successful rights issue, the vehicle risks a slow death spiral or eventual wind-up.
-
Manager relationship fragility. PCG retains the IMA to about 2029 and sued PIA months ago. PIA's economics still flow through an intermediary with its own financial pressures (PCG FY2026 net loss of A$5.6m; listed equities outflows of A$232m).
-
Governance flux. Since October 2025 the board has had three chairs, a near-complete turnover, and its current independence composition and Julian Martin's status are not clearly disclosed. The new director (O'Dea) is linked to both a substantial holder and the manager's parent. Execution of the transition and recapitalisation is therefore uncertain.
Key catalysts and monitorables (next 12 months)
-
First post-buy-back NTA disclosures and the confirmed post-transition portfolio and holdings.
-
The board's decision on the rights issue: size, pricing at NTA and take-up.
-
Disclosure of Antipodes sub-mandate fee terms and any IMA amendment with PIML/PCG.
-
Launch and parameters of the rolling quarterly buy-back.
-
New independent director appointments; board composition and gender diversity.
-
The updated substantial-holder register (WAM, WHSP, Saba, PCG post-buy-back).
-
The 2026 AGM: re-election votes and any spill or structural resolutions.
-
H1 FY2027 results (February 2027), the first under the Antipodes strategy, including transition costs and tax.
-
Whether the ethical screen is formally retained.
-
Final disposition of Takeovers Panel matter TP26/063.
Analyst verdict
Pengana International Equities has spent most of its 22-year life demonstrating the core weakness of the externally managed listed investment company: when performance lags, the discount widens. When the discount widens, capital cannot be raised. When capital cannot be raised, fixed costs bite harder. Under Harding Loevner, PIA earned respectable absolute returns (20.2% in FY2023, 12.6% in FY2025) but consistently trailed the MSCI World, catastrophically so in FY2026 (2.1% against 18.5%). Its manager-aligned board's response in 2025, a leveraged private credit sleeve, was correctly rejected by shareholders as a solution to the wrong problem.
What followed was messy but, on balance, value-accretive for shareholders. The Wilson-led board delivered what activists typically seek: a fully franked special dividend that distributed trapped franking credits, and a buy-back at after-tax NTA less only 0.15 cents of costs. Holders of 58.6% of the shares took that exit, receiving about A$183m at effectively full value. The cost was about A$1.4m of governance expenses, litigation with the manager's parent and a period of acute board instability.
The continuing entity is a different proposition: a roughly A$130m vehicle with a new small/mid-cap mandate run by a well-regarded manager, an ungeared balance sheet, adequate franking for its dividend, and an explicit intention to manage the discount mechanically. Those are genuine positives. But the company is now sub-scale, its fee arrangements with the Antipodes sub-mandate are undisclosed, it still has a contract to 2029 with a recent litigant, and its board is interim and incompletely disclosed.
Verdict: PIA is now an execution story, not a value-unlock story; the value unlock has already been paid out. For continuing holders, the investment merit depends almost entirely on three verifiable events in the next 12 months: a credible recapitalisation, transparent and competitive fee terms, and the early track record of the Antipodes SMID book. Until those are evidenced, a neutral stance is warranted, and the vehicle carries elevated wind-up or merger optionality.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Director | Role | Appointed | Background | Independence |
|---|---|---|---|---|
Francis (Frank) Gooch, B.Bus, CPA | Interim Chair | Re-appointed 16 Sep 2026 (previously director 5 Jun 2017–16 Feb 2026; Chair from 6 Dec 2017) | Former MD of Milton Corporation (CEO 1999, MD 2004–2018); 11 years at Macquarie Bank; former chair of the Australian Listed Investment Companies Association | — |
Brendan O'Dea | Non-executive director | 16 Sep 2026 | CIO of Washington H. Soul Pattinson (appointed Oct 2021, per 2023 press reporting); former MD and CEO of Milton Corporation; 22 years at Citigroup (Sydney, Hong Kong, New York, Tokyo); non-executive director of Pengana Capital Group since April 2023 | — |
Richard Caldwell, BEc/LLB, Grad Dip Applied Finance | Independent NED; Chair of Audit, Risk & Compliance Committee | 21 Oct 2025 | Senior roles at Citibank Sydney, JP Morgan London and Tricom; listed directorships including Southern Hemisphere Mining (ASX: SUH) and Greatcell Solar | Independent |
Julian Martin, B.Ec, Harvard OPM, MAICD | Independent NED | 21 Oct 2025 | Founding CEO of Mojo New York; co-founder of Chiat/Day/Mojo London; Executive Director at BBH London; SecondBite Chair 2020–2023 | Independent. Status uncertain: the 16 Sep 2026 release said he would resign on 29 Sep 2026, but the 30 Sep 2026 release listed only Jollie, Wilson and Hamilton as resigning. |
Board of Directors — Brett Jollie
| Director | Role | Tenure | Exit |
|---|---|---|---|
Brett Jollie | Independent NED (from 27 Nov 2025); Chair (16 Feb–29 Sep 2026) | 10 months | Resigned 29 Sep 2026. Background: 23 years at Aberdeen Asset Management (14 as Australian CEO); former CEO of Hearts & Minds Investments; appointed CEO of U Ethical on 7 Apr 2026. |
Geoff Wilson AO | Non-independent NED | 21 Oct 2025–29 Sep 2026 | Resigned after buy-back. Founder of Wilson Asset Management (1997); chairs eight WAM LICs. |
Jesse Hamilton, CA | Non-independent NED | 21 Oct 2025–29 Sep 2026 | Resigned. CFO of Wilson Asset Management (International). |
Russel Pillemer | Managing Director | 5 Jun 2017–21 Oct 2025 | Removed by shareholders |
David Groves | Non-independent NED | 13 Jan 2017–21 Oct 2025 | Removed by shareholders; former independent Chair of PCG |
Sandi Orleow, CFA | Independent NED; ARCC Chair | 1 Sep 2019–21 Oct 2025 | Removed by shareholders |
Directors' Remuneration
| Director (FY2026) | Fees (AUD) | Superannuation (AUD) | Total (AUD) |
|---|---|---|---|
Frank Gooch | 42,000 | 5,040 | 47,040 |
Brett Jollie | 22,545 | 2,705 | 25,250 |
Julian Martin | 18,730 | 2,248 | 20,978 |
Richard Caldwell | 18,730 | 2,248 | 20,978 |
Sandi Orleow | 15,750 | 1,890 | 17,640 |
David Groves | 15,680 | 0 | 15,680 |
Geoffrey Wilson | 6,244 | 749 | 6,993 |
Jesse Hamilton | 6,244 | 749 | 6,993 |
Total | 145,923 | 15,629 | 161,552 |
Board fee schedule (AUD, incl. super) | FY2022 | FY2023 | FY2024 |
Chair fee (AUD) | 66,000 | 66,300 | 66,600 |
Independent NED fee (AUD) | 44,000 | 44,200 | 44,400 |
Total board remuneration (AUD) | 154,000 | 154,700 | 160,950 |
Major Shareholders
| Holder | Shares | % |
|---|---|---|
Wilson Asset Management Group | 30,528,459 | 11.83 |
Saba Capital Management GP, L.L.C. | 25,617,001 | 9.94 |
Washington H. Soul Pattinson and Company Limited | 24,470,580 | 9.51 |
Major Shareholders by Rank
| Rank | Holder | Shares | % |
|---|---|---|---|
| 1 | WHSP Holdings Pty Ltd | 24,470,580 | 9.49 |
| 2 | WAM Strategic Value Limited | 23,028,459 | 8.93 |
| 3 | Citicorp Nominees Pty Ltd (likely including Saba) | 21,455,752 | 8.32 |
| 4 | BNP Paribas Nominees Pty Ltd | 9,245,526 | 3.58 |
| 5 | Netwealth Investments Limited | 7,457,687 | 2.89 |
| 6 | HSBC Custody Nominees (Australia) Limited | 6,659,604 | 2.58 |
| 7 | BNP Paribas NOMS Pty Ltd | 4,256,992 | 1.65 |
| 8 | Morgan Stanley Australia Securities (Nominee) | 3,964,105 | 1.54 |
| 9 | Pengana Capital Ltd | 3,454,815 | 1.34 |
| 10 | Netwealth Investments Limited (second account) | 3,028,417 | 1.17 |
Competitive Landscape
Key Competitors
| # | Competitor | Vehicle type | Relevance to PIA |
|---|---|---|---|
| 1 | WAM Global Limited (ASX: WGB) | Global equity LIC (Wilson Asset Management) | Direct LIC peer; manager-affiliated with PIA's 2025–26 activist; allegedly proposed a combination with PIA |
| 2 | MFF Capital Investments (ASX: MFF) | Global equity LIC (concentrated quality) | Largest-scale global LIC comparator |
| 3 | Future Generation Global (ASX: FGG) | Global fund-of-managers LIC (philanthropic) | Retail global LIC; Wilson-founded |
| 4 | Hearts and Minds Investments (ASX: HM1) | Global high-conviction LIC | Former CEO Brett Jollie served on PIA's board |
| 5 | Platinum Capital (ASX: PMC) | Global equity LIC | — |
| 6 | Magellan Global Fund (ASX: MGF) | Listed global equity fund | — |
| 7 | Antipodes Global Shares (Quoted Managed Fund) | Active ETF / QMF | Same manager as PIA's new mandate; trades near NAV, a structural competitor |
| 8 | Hyperion Global Growth Companies (Managed Fund) / Magellan / other active global ETFs | Active ETFs | NAV-priced alternatives that remove discount risk |
| 9 | Vanguard MSCI Index International Shares ETF (ASX: VGS) and iShares/BetaShares global ETFs | Passive ETFs | Low-cost benchmark exposure; PIA's main structural threat |
| 10 | Ethical global ETFs (e.g. BetaShares Global Sustainability Leaders, ETHI) | Passive ethical ETFs | Direct substitute for PIA's ethical proposition |
| 11 | Pengana Harding Loevner International Fund | Unlisted managed fund | In-house sister product (same strategy to 2026) |
Peer Comparison FY2026
| Metric | PIA FY2025 | PIA FY2026 |
|---|---|---|
Net assets (AUD Mn) | 352.8 | 313.4 |
Total portfolio return (%) | 12.6 | 2.1 |
Benchmark return (%) | 14.6 | 18.5 |
Total expenses / average net assets (%) | 1.58 | 2.05 |
Management fee rate on gross portfolio (%) | 1.20 | 1.20 |
Ordinary DPS (AUD cents) | 5.40 | 5.55 |
Discount to pre-tax NTA at year end (%) | 15.1 | — |
R&D intensity (%) | 0 | 0 |
Recent Developments
There were no layoffs or hiring (no employees), no product launches and no regulatory enforcement actions beyond the ASX query and the Takeovers Panel application.



